These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16606405)

  • 1. A biventricular ICD system with biventricular defibrillation.
    Spurrell P; Gandhi M; Rinaldi CA
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):334-6. PubMed ID: 16606405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
    Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):790-4. PubMed ID: 15250864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present understanding of shock polarity for internal defibrillation: the obvious and non-obvious clinical implications.
    Kroll MW; Efimov IR; Tchou PJ
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):885-91. PubMed ID: 16923006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel use of a vascular plug to anchor an azygous vein ICD lead.
    Bar-Cohen Y; Takao CM; Wells WJ; Saxon LA; Cesario DA; Silka MJ
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):99-102. PubMed ID: 19549034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
    Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
    J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is DFT testing still mandatory?].
    Neuzner J
    Herz; 2005 Nov; 30(7):601-6. PubMed ID: 16333585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reduction of a high defibrillation threshold by a combined implantation of a subcutaneous array and azygos vein lead.
    Yamada T; Robertson PG; McElderry HT; Doppalapudi H; Plumb VJ; Kay GN
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e173-6. PubMed ID: 22360586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.
    Day JD; Olshansky B; Moore S; Brown S; Stolen KQ; Lerew DR;
    Europace; 2008 Mar; 10(3):347-50. PubMed ID: 18308755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
    Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of biventricular and conventional transvenous defibrillation: a computational study using patient derived models.
    Mocanu D; Kettenbach J; Sweeney MO; Kikinis R; Kenknight BH; Eisenberg SR
    Pacing Clin Electrophysiol; 2004 May; 27(5):586-93. PubMed ID: 15125713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of high defibrillation threshold.
    Uyguanco ER; Berger A; Budzikowski AS; Gunsburg M; Kassotis J
    Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1237-48. PubMed ID: 18939911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.
    Lopez JA
    Europace; 2012 Jun; 14(6):853-8. PubMed ID: 22333241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.